相关实验视频

Updated: Sep 12, 2025

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

脂质纳米粒子介导的向mRNA传递及其在癌症治疗中的应用

Yuan Sui¹, Xiaowen Hou^2,3,4, Juan Zhang^3,5

¹School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, China. hongbowangyt@gmail.com.

Journal of materials chemistry. B

|August 4, 2025

概括

使者RNA (mRNA) 脂质纳米颗粒 (LNP) 显示出癌症治疗的前景. 本综述详细介绍了LNP优化,向输送和各种mRNA癌症治疗应用.

科学领域:

生物技术和生物医学工程生物技术和生物医学工程
在瘤学瘤学.
分子和细胞生物学分子和细胞生物学

背景情况:

使者RNA (mRNA) 技术已经取得了显著的进步,特别是其在COVID-19疫苗中的作用.
有效的mRNA疗法需要有效的细胞内输送蛋白质表达,需要先进的输送系统.
脂质纳米颗粒 (LNP) 对于mRNA疗法的临床成功至关重要,使得有效的输送.

研究的目的:

在癌症治疗中提供mRNA-脂质纳米粒子 (mRNA-LNP) 应用的全面审查.
总结优化LNP组成和合成的策略,以提高治疗效果.
探索mRNA-LNP技术在各种癌症治疗模式中的多样化应用.

主要方法:

对癌症治疗中mRNA-LNP技术的当前文献进行系统审查.
对LNP配方优化策略的分析,包括AI驱动的方法.
在瘤学背景下检查mRNA-LNP的向传递技术.

主要成果:

液态核蛋白是一种关键技术,使得基于mRNA的癌症疗法的临床转化成为可能.
优化的LNP组成和合成方法提高了mRNA递送效率和治疗结果.
不同的应用包括mRNA瘤疫苗,采用细胞转移,瘤抑制器恢复和免疫调节.

结论:

mRNA-LNP技术在推进癌症治疗策略方面具有巨大的潜力.
对LNP优化,向性交付和新型应用的持续研究将推动未来的治疗发展.
应对当前的挑战对于实现mRNA-LNP癌症疗法的全部临床影响至关重要.

更多相关视频

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on: January 20, 2023

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...